Navigation Links
Cepheid Reports Fourth Quarter And Full Year 2012 Results
Date:1/24/2013

p>13,44610,298Amortization of intangible assets 

4,9656,523Amortization of terminated patent license and impairment of acquired intangible assets

1,3995,372Stock-based compensation related to employees and consulting services rendered

24,49619,768Changes in operating assets and liabilities:Accounts receivable 

(6,443)(7,830)Inventory 

(5,105)(23,982)Prepaid expenses and other current assets 

(2,714)(237)Other non-current assets

(172)(122)Accounts payable and other current liabilities 

(5,740)11,365Accrued compensation 

(1,736)5,334Deferred revenue 

575(2,084)Net cash provided by operating activities 

2,92827,032Cash flows from investing activities:Capital expenditures 

(23,150)(18,922)Cash paid for intangible asset

(2,140)-Payments for technology licenses 

-(1,655)Cost of acquisitions, net

(24,021)(296)Net cash used in investing activities 

(49,311)(20,873)Cash flows from financing activities:Net proceeds from the issuance of common shares and exercise of stock options

27,07935,857Proceeds from notes payable

156-Principal payment of notes payable

(72)(6,669)Net cash provided by financing activities 

27,16329,188Effect of exchange rate change on cash

(9)123Net increase (decrease) in cash and cash equivalents 

(19,229)35,470Cash and cash equivalents at beginning of period 

115,00879,538Cash and cash equivalents at end of period

$   95,779$  115,008 CEPHEID  

RECONCILIATION OF GAAP TO NON-GAAP MEASURES (UNAUDITED)(in thousands, except per share data)Three Months Ended
December 31,Years Ended
December 31,2012201120122011Cost of product sales$ 42,896$ 38,632$ 153,365$ 122,840  Stock compensation expense(808)(443)(3,037)(1,684)  Impairment of i
'/>"/>

SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Cepheid to Webcast Upcoming Financial Presentations
2. Cepheid Announces Executive Vice President Emerging Markets
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 inhibitor ... both dose groups. The primary endpoint assessed the proportion ... with data reported in previous trials, the most common ... results will be presented at an upcoming medical congress. ...
(Date:5/17/2013)... -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a ... today announced that it will release its unaudited financial results ... on Tuesday, May 28, 2013.  The Company will host a ... EDT (May 28, 2013 at 8:00 p.m. China Standard Time) ... on recent corporate developments. To access the conference ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
(Date:5/19/2013)... (PRWEB) May 19, 2013 Today, ... small business health insurance . Zane Benefits, ... employer sponsored health benefits, is the leader in ... health reimbursement arrangements . , According to ... the self-employed intrinsically know the value of small ...
(Date:5/19/2013)... These molecular diagnostics market reports ... Japan, Italy, Germany and France:, ... practice, as well as key economic, regulatory, demographic, ... during the next five years. ,     An ... test formats, detection methodologies, trends in testing automation ...
(Date:5/19/2013)... 2013 Americans live closer to their ... American Veterinary Medical Association (AVMA) U.S. Pet Ownership and ... consider their dog a member of the family, up ... much five years earlier. , According to the American ... national income dedicated to pets has increased every year ...
(Date:5/19/2013)... 2013 Vegas Hotel Escapes, the premier ... announce the launch it's all new vacation packages for ... on 5/19/2013. Consumers traveling to Las Vegas will be ... on VegasHotelEscapes.com's website. Travelers will be pleased to know ... price. , Vegas Hotel Escapes specializes in helping consumers ...
(Date:5/19/2013)... 2013 Passages Malibu, the leading non-12 ... announced this week the launch of a “Sobriety, Health, ... media channels. “We are always looking for new ... to get feedback regarding sobriety, what’s working for people, ... of the Passages Addiction Treatment Centers located ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3
... celebritiesParis Hilton, Nicole Ritchie, Michelle Rodriguez and Lindsay Lohanyielded ... any public health context, according to a new report ... Public Health,s Center for Injury Research and Policy. Analyzing ... and the evening news broadcasts from ABC, NBC, CBS, ...
... produces more greenhouse gases, researchers say , , WEDNESDAY, April ... than protect your health. It also may help ... of Hygiene & Tropical Medicine say that because food ... lean population, such as in Vietnam, consumes about 20 ...
... WASHINGTON, April 22 Newly established CandleInTheWindow.org announces ... or symbol that tells pregnant women in need that the ... they need. "We want to get beyond the labels of ... pregnant women that in Everyneighborhood, USA there are ...
... Researchers at the UC San Diego School of Medicine and ... type of immune system cell thought to be part of ... help promote its spread. They have found that when these ... (RANK ligand), breast cancer is more likely to spread to ...
... Privacy, Security and Policy Development to Netsmart,s CareConnect(TM) ... , GREAT RIVER, N.Y., April 22 ... software and services for health and human services ... information exchange (HIE) consulting firm Object Health LLC, ...
... DATA ), a technology and services company ... industry, today reported a multi-year agreement with the Portuguese ... member of DATATRAK,s CRO Connect Program(TM), Keypoint is able ... empower its staff to more efficiently manage both its ...
Cached Medicine News:Health News:Media ignores health consequences of drinking and driving among young celebrities 2Health News:Staying Slim Is Good for the Environment 2Health News:$1000 Scholarship/Award for Best Poster/Ribbon Design That Encourages Needy Pregnant Women to Ask Bearers for Help 2Health News:Instead of fighting breast cancer, immune cell promotes its spread 2Health News:Netsmart Technologies Announces Partnership With Health Information Exchange Consulting Firm Object Health 2Health News:Netsmart Technologies Announces Partnership With Health Information Exchange Consulting Firm Object Health 3Health News:Netsmart Technologies Announces Partnership With Health Information Exchange Consulting Firm Object Health 4Health News:Keypoint Joins DATATRAK's CRO Connect Program(TM) 2Health News:Keypoint Joins DATATRAK's CRO Connect Program(TM) 3Health News:Keypoint Joins DATATRAK's CRO Connect Program(TM) 4
... Used retrograde to ... establish a Peel-Away ureteral ... The temporary protective Peel-Away ... away as the ureteroscope ...
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....
Medicine Products: